🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT04969042
Recruiting Phase 1

Closed-loop Functional Spinal Cord Stimulation in Patients With Spinal Cord Injury

NCT04969042 · tracked via the Priya Life Science China tracker
Sponsor
Luming Li
Phase
Phase 1
Started
2021-08-01
Last updated
2021-07-20

Condition(s) studied

Spinal Cord Injuries

Investigational drug(s) / intervention(s)

Pins Medical G122 RS

Pins Medical G122 RS: G122RS model implanted spinal cord stimulation device, which could give closed-loop functional stimulation in the epidural space

Study summary

The purpose of this experiment is to evaluate the efficacy of Closed-loop Functional Spinal Cord Stimulation on Walking Rehabilitation in Patients after Spinal Cord Injury

Eligibility

Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * Age 18\~70 * Spinal cord injury staging(AIS) A,B,C or D * Level of lesion is T10 and above * Distance between lesion and conus \>60mm * Injured Time \> 3 months * Capable of participating rehabilitation program * Agree to comply with all conditions of the study and to attend all required study training and visits Exclusion Criteria: * With Obvious psychiatric disorder that cannot complete relevant questionaires * Cognitive impairment * Severe autonomic reflex disorder * Severe muscle atrophy and joint contracture * Cannot participate in spinal cord stimulation surgery or follow-up visits * Life expectancy less than 12 months * Abnormal blood or other physiological examinations that cannot conduct surgery, such as blood coagulation disorder or kidney/liver abnormalities * Uncontrollable hypertension, heart diseases, respiratory diseases or took related medicine in last 3 months * Unsuitable candidates in PI's perspective

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
National Engineering Laboratory for Neuromodulation Beijing Beijing Municipality Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04969042 on ClinicalTrials.gov ↗ ← All trials in China